Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
Research uncovers new driver of immunotherapy resistance in pancreatic cancer
EIC Accelerator: strong performance of engineering and tech-based companies
Ibex raises $55m to drive global adoption of AI for cancer diagnosis
Valhalla Ventures launches $66M fund to back deeptech innovators